Oral Presentation
Late-breaking translational research in lung cancer
Chairs
D. Lam
Hong Kong SAR
(Hong Kong)
14:45
Introduction
J. Domagała-Kulawik(Warszawa, Poland)
COI
1
OA6008
15:00
LSC Abstract – A requirement for IKKa in lung adenocarcinoma
M. Vreka(München, Germany)
COI
2
15:15
Tumor cell-derived osteopontin promotes lung metastasis via both cell-autonomous and paracrine pathways
I. Giopanou(Rio (Patras), Greece)
COI
3
15:30
Effect of 17-oxo-DHA alone and in combination with gemcitabine on lung cancer cell growth
L. Siena(Palermo, Italy)
COI
4
15:45
Encapsulation of vinorelbine in polymeric nanoparticles improves efficacy in cancer cells and reduces inflammation in non-cancer cells
A. Cryer(London, United Kingdom)
COI
5
16:00
RBM5 overexpression reverses acquired resistance to gefitinib in PC9/AB2 NSCLC cells
J. Zhang(Changchun (Jilin), China)
COI
6
16:15
IL-17C promotes tumor-associated inflammation and lung tumor growth
C. Jungnickel(Homburg, Germany)
COI
7
16:30
Cell intrinsic and environmental factors influencing human bronchial epithelial cell migration
F. Millar(Edinburgh, United Kingdom)
COI
8
. . .
